Login / Signup

Purification and Characterization of a Novel Fibrinolytic Enzyme from Marine Bacterium Bacillus sp. S-3685 Isolated from the South China Sea.

Zibin MaJeevithan ElangoJianhua HaoWen-Hui Wu
Published in: Marine drugs (2024)
A novel fibrinolytic enzyme, BSFE1, was isolated from the marine bacterium Bacillus sp. S-3685 (GenBank No.: KJ023685) found in the South China Sea. This enzyme, with a molecular weight of approximately 42 kDa and a specific activity of 736.4 U/mg, exhibited its highest activity at 37 °C in a phosphate buffer at pH 8.0. The fibrinolytic enzyme remained stable over a pH range of 7.5 to 10.0 and retained about 76% of its activity after being incubated at 37 °C for 2 h. The K m and V max values of the enzyme at 37 °C were determined to be 2.1 μM and 49.0 μmol min -1 mg -1 , respectively. The fibrinolytic activity of BSFE1 was enhanced by Na + , Ba 2+ , K + , Co 2+ , Mn 2+ , Al 3+ , and Cu 2+ , while it was inhibited by Fe 3+ , Ca 2+ , Mg 2+ , Zn 2+ , and Fe 2+ . These findings indicate that the fibrinolytic enzyme isolated in this study exhibits a strong affinity for fibrin. Moreover, the enzyme we have purified demonstrates thrombolytic enzymatic activity. These characteristics make BSFE1 a promising candidate for thrombolytic therapy. In conclusion, the results obtained from this study suggest that our work holds potential in the development of agents for thrombolytic treatment.
Keyphrases
  • pulmonary embolism
  • stem cells
  • hydrogen peroxide
  • heavy metals
  • risk assessment
  • cell therapy
  • chemotherapy induced